Alison Messom - Bergenbio ASA Director Operations
| BGBIO Stock | NOK 10.87 0.48 4.23% |
Insider
Alison Messom is Director Operations of Bergenbio ASA
| Age | 52 |
| Phone | 47 55 96 11 59 |
| Web | https://www.bergenbio.com |
Bergenbio ASA Management Efficiency
The company has return on total asset (ROA) of (0.4939) % which means that it has lost $0.4939 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (0.9551) %, meaning that it generated substantial loss on money invested by shareholders. Bergenbio ASA's management efficiency ratios could be used to measure how well Bergenbio ASA manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
| Showing other executives | INSIDER Age | ||
| Marianne Stigset | Aker Horizons AS | N/A | |
| Tove Anderson | Equinor ASA | N/A | |
| Alasdair Cook | Equinor ASA | 48 | |
| Tore Medhus | Sparebank 1 SR | 58 | |
| Kari BechMoen | DnB ASA | 42 | |
| Rita Skjaervik | Telenor ASA | 49 | |
| Frode B | Sparebank 1 SR | 55 | |
| Holger Dilling | Aker Horizons AS | 52 | |
| Tom Preststulen | Elkem ASA | 76 | |
| Mirella Grant | DnB ASA | 54 | |
| Nanna Tollefsen | Aker Horizons AS | N/A | |
| Anne Moen | DnB ASA | 59 | |
| Christian Yggseth | Aker Horizons AS | N/A | |
| Joachim Bjorni | Aker ASA | N/A | |
| Siv Torstensen | Equinor ASA | 53 | |
| Petter Lange | Sparebank 1 SMN | N/A | |
| Jan Friestad | Sparebank 1 SR | 57 | |
| Martin Holte | Aker ASA | 44 | |
| Erik Nyborg | Aker Horizons AS | N/A | |
| Trond Christophersen | Norsk Hydro ASA | 51 | |
| Oeyvind Eriksen | Aker ASA | 59 | |
Management Performance
| Return On Equity | -0.96 | |||
| Return On Asset | -0.49 |
Bergenbio ASA Leadership Team
Elected by the shareholders, the Bergenbio ASA's board of directors comprises two types of representatives: Bergenbio ASA inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Bergenbio. The board's role is to monitor Bergenbio ASA's management team and ensure that shareholders' interests are well served. Bergenbio ASA's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Bergenbio ASA's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Rune Skeie, Chief Officer | ||
| Debbie Molyneux, Chief Officer | ||
| Nigel MSc, Chief Officer | ||
| Alison Messom, Director Operations | ||
| James Barnes, Chief Officer | ||
| Cristina MD, Chief Officer | ||
| Martin Olin, Chief Officer | ||
| Gayle MBA, Chief Officer | ||
| Akil Jackson, Medical Director |
Bergenbio Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Bergenbio ASA a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -0.96 | |||
| Return On Asset | -0.49 | |||
| Operating Margin | (383.14) % | |||
| Current Valuation | 421.26 M | |||
| Shares Outstanding | 88.66 M | |||
| Shares Owned By Insiders | 34.95 % | |||
| Shares Owned By Institutions | 19.17 % | |||
| Price To Book | 3.92 X | |||
| Price To Sales | 756.59 X | |||
| Revenue | 774 K |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectOther Information on Investing in Bergenbio Stock
Bergenbio ASA financial ratios help investors to determine whether Bergenbio Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Bergenbio with respect to the benefits of owning Bergenbio ASA security.